Clinical trial
Randomized Open-Label Controlled Trial Evaluating the Efficacy of the Combination of Progesterone and Low Molecular Weight Heparin in Recurrent Pregnancy Loss
NCT07796737 is registered in ClinicalTrials.gov with General University Hospital, Prague as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Open-Label Controlled Trial Evaluating the Efficacy of the Combination of Progesterone and Low Molecular Weight Heparin in Recurrent Pregnancy Loss
- Lead sponsor
- General University Hospital, Prague
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- December 1, 2026
- Completion date
- December 31, 2030
- Enrollment
- 264 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pregnancy loss, pregnancy loss, early